Iron Homeostasis-Related Parameters and Hepcidin/Ferritin Ratio: Emerging Sex-Specific Predictive Markers for Metabolic Syndrome
- PMID: 39330480
- PMCID: PMC11434056
- DOI: 10.3390/metabo14090473
Iron Homeostasis-Related Parameters and Hepcidin/Ferritin Ratio: Emerging Sex-Specific Predictive Markers for Metabolic Syndrome
Abstract
Metabolic syndrome (MetS) is a worldwide public health challenge. Accumulating evidence implicates elevated serum ferritin and disruptions in iron metabolism as potential elements linked to an increased risk of MetS. This study investigates the relationship between iron homeostasis-including hepcidin levels, serum iron concentration, unsaturated iron-binding capacity (UIBC), and the hepcidin/ferritin (H/F) ratio-and MetS. In this descriptive cross-sectional study, 209 participants aged 24-70 were categorized into two groups: 103 with MetS and 106 without MetS. All participants underwent medical assessment, including anthropometric measures, indices of glycemic control, lipid profiles, and iron-related parameters. Participants were further stratified by the Homeostasis Model Assessment-Insulin Resistance index into three subgroups: insulin-sensitive (IS) (<1.9), early insulin resistance (EIR) (>1.9 to <2.9), and significant insulin resistance (SIR) (>2.9). Notable increments in serum ferritin and hepcidin were observed in the SIR group relative to the IS and EIR groups, with a significant association between metabolic parameters. The UIBC and serum ferritin emerged as significant predictors of MetS, particularly in men, with an area under the curve (AUC) of 0.753 and 0.792, respectively (p ≤ 0.001). In contrast, hepcidin was notably correlated with MetS in women, with an AUC of 0.655 (p = 0.007). The H/F ratio showed superior predictive capability for MetS across both sexes (at cutoff level = 0.67). Among women, this ratio had an AUC of 0.639 (p = 0.015), and for men, it had an AUC of 0.792 (p < 0.001). Hypertension proved an independent risk factor for MetS, affirming its role in metabolic dysregulation. The findings highlight a significant interconnection between iron homeostasis parameters and MetS, with sex-specific variations underscoring the importance of personalized diagnostic criteria. The crucial role of the H/F ratio and the UIBC as emerging predictive markers for MetS indicates their potential utility in identifying at-risk individuals. Further longitudinal research is essential to establish causality and explore the interplay between these biomarkers and MetS.
Keywords: HOMA-IR; ferritin; hepcidin; insulin resistance; insulin-sensitive; metabolic syndrome.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Association of serum ferritin levels with metabolic syndrome and insulin resistance in a Chinese population.J Diabetes Complications. 2017 Feb;31(2):364-368. doi: 10.1016/j.jdiacomp.2016.06.018. Epub 2016 Jun 23. J Diabetes Complications. 2017. PMID: 27426616
-
Insight into the Predictive Power of Surrogate Diagnostic Indices for Identifying Individuals with Metabolic Syndrome.Endocr Metab Immune Disord Drug Targets. 2024;24(11):1291-1302. doi: 10.2174/0118715303264620231106105345. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38258774
-
Comparison of Novel Biomarkers of Insulin Resistance With Homeostasis Model Assessment of Insulin Resistance, Its Correlation to Metabolic Syndrome in South Indian Population and Proposition of Population Specific Cutoffs for These Indices.Cureus. 2023 Jan 11;15(1):e33653. doi: 10.7759/cureus.33653. eCollection 2023 Jan. Cureus. 2023. PMID: 36788883 Free PMC article.
-
Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.Mol Metab. 2016 Oct 31;6(1):38-47. doi: 10.1016/j.molmet.2016.10.006. eCollection 2017 Jan. Mol Metab. 2016. PMID: 28123936 Free PMC article.
-
Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?Curr Pharm Des. 2020;26(10):1025-1035. doi: 10.2174/1381612826666200131103018. Curr Pharm Des. 2020. PMID: 32003680 Review.
Cited by
-
The Interplay Between Iron Metabolism and Insulin Resistance: A Key Factor in Optimizing Obesity Management in Children and Adolescents.Nutrients. 2025 Mar 30;17(7):1211. doi: 10.3390/nu17071211. Nutrients. 2025. PMID: 40218969 Free PMC article. Review.
-
Metabolomics and nutrient intake reveal metabolite-nutrient interactions in metabolic syndrome: insights from the Korean Genome and Epidemiology Study.Nutr J. 2025 Aug 19;24(1):128. doi: 10.1186/s12937-025-01189-3. Nutr J. 2025. PMID: 40830960 Free PMC article.
References
-
- Mohamed S.M., Shalaby M.A., El-Shiekh R.A., El-Banna H.A., Emam S.R., Bakr A.F. Metabolic syndrome: Risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chem. Adv. 2023;3:100335. doi: 10.1016/j.focha.2023.100335. - DOI
-
- Wu S., Xu W., Guan C., Lv M., Jiang S., Jinhua Z. Global burden of cardiovascular disease attributable to metabolic risk factors, 1990-2019: An analysis of observational data from a 2019 Global Burden of Disease study. BMJ Open. 2023;13:e069397. doi: 10.1136/bmjopen-2022-069397. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous